bioRxiv · 10.64898/2026.05.29.728784
Microbial Dynamics Across Commercial Spaceflights of Varying Duration
Abstract
SummarySpaceflight introduces environmental stressors that can alter human microbiomes and immune responses. We analyzed 259 biospecimens from six astronauts across two commercial ISS missions: Axiom 2 (10-day mission) and Axiom 3 (21-day mission). Samples included saliva, stool, urine, and body swabs from 10 anatomical sites, profiled via 16S ribosomal RNA (rRNA) gene sequencing. Gut and oral microbiomes remained stable, while skin-associated communities exhibited transient diversity shifts post-flight. Taxonomic analysis revealed individual and site-specific patterns as well as a possible microbial acquisition from the ISS/space-flight environment and microbiome exclusivity. Cytokine profiling from single cell data indicated immune activation, with IL-32 and IL-16 elevated in Axiom 2 and Axiom 3, coinciding with microbial changes. These findings provide an integrated view of microbiome individuality, exclusivity and immune dynamics during two short-duration commercial spaceflights of three weeks, informing strategies for crew health on future long-duration missions.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Krishnavajhala, A., Gingras, M.-C., Santiago-Rodriguez, T., Chen, Y., Bandaranaike, D., Bhamidipati, S., Xiang, Q., Kottapalli, K., Momin, Z., Santhanam, A., Walker, K., Wang, Q., Griffin, S. M., Masternak, M. M., Ross, M. C., Muzny, D., Wu, J., Urquieta, E., Gibbs, R., doddapaneni, H.. 2026-05-30. Microbial Dynamics Across Commercial Spaceflights of Varying Duration. https://doi.org/10.64898/2026.05.29.728784
Cite the original work for its findings. Save a collection to share your selection of sources.